Benzinga | Oct 15, 2020 07:38AM EDT

Wells Fargo Maintains Equal-Weight on Iovance Biotherapeutics, Raises Price Target to $35

Wells Fargo maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Equal-Weight and raises the price target from $29 to $35.